Treating 'atomic bomb' caused by coronavirus
Inmune Bio CEO, President and acting CMO Dr. Raymond Tesi, M.D. talks about Inmune Bio's phase two human trials of possible treatment of coronavirus patients using an anti-inflammatory drug and addresses the effort for lower drug costs.
No comments:
Post a Comment